Saturday, 28 May 2022

Translumina to set up Asia's largest heart valve manufacturing facility at AMTZ Vizag

28 December 2021 | News

Upon completion, the facility shall produce path breaking Transcatheter Heart Valve Technologies for all kinds of valve diseases for the world market

Translumina, based in India and Germany, has performed the foundation stone laying ceremony of Asia's Largest Heart Valve manufacturing facility at Andhra Pradesh Medtech Zone (AMTZ) in Vizag.

"We have partnered with some of the best institutions and physicians around the world to create next-generation heart valve technologies to offer better clinical outcomes at an affordable cost for all kinds of valve disorders." said Gurmit Singh Chugh, MD and Co-founder, Translumina.

"We plan to complete the facility by December 2022 with more than 100,000 square feet of manufacturing space with the state-of-the-art equipment and infrastructure," said Punita Sharma Arora, Co-Founder, Translumina.

Heart valve disorders which traditionally were treated by an open-heart Surgery, are prevalent significantly worldwide. However, in the last few years, Transcatheter Heart valve Implantation (using a catheter without opening the heart) has made the procedure simple, safe and effective with a minimally invasive approach. However, the prohibitive cost of the transcatheter valves, along with niche indications, have made therapy limited to very few patients.






× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account